I
Integrated Biosciences
Combining synthetic biology and machine learning to regulate cellular stress responses, the company develops next-generation therapeutics
About Integrated Biosciences
Integrated Biosciences is a biotechnology company that is pioneering the use of synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases. The company's integrated discovery platform combines synthetic biology, AI-driven small-molecule drug discovery, optogenetics, chemistry, and computation to unravel complex biology and target cellular stress responses associated with conditions like neurodegeneration, cancer, and diabetes.
Integrated Biosciences operates in the biotechnology and pharmaceutical markets, with a focus on the development of drugs to treat age-related illnesses. The company's business model is centered around research and development, with the goal of discovering and developing new drugs that can be commercialized. The company has recently secured $17 million in funding to accelerate the development of its drug pipeline.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- Redwood City, United States
- Employees
- 17
- Open positions
- 3
- Dealroom signal
- 91.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Spinout, Biotech and Pharma, AI Drug Discovery, Techbio, AI Applications, DT and LS
- Technology
- Artificial Intelligence
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Aug 2026 | $68M | $274M | Undisclosed | ↗ |
| SEED✓Equity / VC | Oct 2024 | $17M | $69M | Michael Stoppelman · Overlap Holdings · Sutter Hill Ventures · Vijay Pandurangan | ↗ |
Growth signals
Latest recorded traffic for Integrated Biosciences is 8.5K monthly website visits, up 42400% over the last three months. Integrated Biosciences's team grew 6.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed13 investors entered at this stage
Reinforced Ventures
Sutter Hill Ventures
Michael Stoppelman
Overlap Holdings
Vijay Pandurangan
Illumina Ventures
Civilization Ventures
Mission BioCapital
Conscience VC
Root Ventures
Polymath Capital
LifeSpan Vision Ventures
Sabrina Hahn
Other known investors3 additional known investors
Massachusetts Institute of Technology
University of California, Santa Barbara
MBC Biolabs
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Integrated Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Integrated Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.